Find It®
Tailor treatment decisions based on somatic mutations in your patient’s tumor.
At Canexia Health, we make high-quality cancer genomic information accessible and affordable with our clinically-validated assays, informatics, and support.
Solutions that drive precision oncology
Do More for Your Patients
Only a small percentage of cancer patients receive genomic biomarker testing that could match them with targeted treatments demonstrated to improve outcomes. We pair the latest advances in oncology with machine learning to provide cancer professionals with the insights needed to make targeted treatment decisions for their patients.
Our Solutions
Follow It®
A minimally invasive option for biopsy, Follow It can also be used to monitor cancer progression or investigate treatment resistance.
Fusions
Rapid, cost-effective, and clinically actionable, Fusions allows you the flexibility to isolate and interrogate relevant fusions.
Canexia Informatics Platform
Make more informed treatment decisions by using detailed results for therapeutic recommendations and expertly curated clinical trials information provided in our comprehensive reporting software.
Your Labs, Our Technology
Conduct world-leading mutation assays for cancer patients, right from your laboratory. Our cloud-based analytics platform allows partner labs access to our proprietary informatics software suite covering the full stack of molecular and computational quality assurance, genome analytics, mutation interpretation, and report generation.
Our Partners
“We have found the FIND-IT assay to be a reliable, quick and cost-effective tool for identifying driver mutations in fixed tissue samples from across Australia. This has had direct implications for identifying patients suitable for targeted therapies, especially those with lung cancer, colorectal cancer and melanoma. However, the scope of the test is such that there is also interest in the panel for patients with a variety of other cancers, including breast and endometrial cancers.” Professor Graeme Suthers, Sonic Genetics
Recent Resources
Blog
April 20, 2021
Using Machine Learning to Enhance Precision Oncology
Precision medicine instruments produce incredible amounts of data, sometimes measured in terabytes or even petabytes.
Press
March 11, 2021
Cancer patients must not become collateral damage in fight against pandemic
If we are to minimize the now well-documented burdens of COVID-19 on cancer patients, governments must support innovations that improve their outcomes and cut through the healthcare roadblocks posed by the pandemic.
Blog
March 2, 2021
Assessing the Real World Accuracy of ctDNA Diagnostics
Canexia Health's Chief Scientific Officer writes about the importance of combining different approaches to obtain correct results for ctDNA diagnostics. While high sensitivity is important, it must be contextualized with other key measurements.
Get in Touch
Contact us today to learn about our end-to-end solution, from mutation identification to auto-generated clinical reports.